Cellules stromales mésenchymateuses: Vecteurs cellulaires de nanoparticules au sein de tumeurs cérébrales

Medecine/Sciences

Volumn 27, Issue 3, 2011, Pages 234-236

  Roger, Mathilde ^a   Clavreul, Anne ^a,b   Menei, Philippe ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; NANOPARTICLE;

ANIMAL; BRAIN TUMOR; CYTOLOGY; MESODERM; NOTE; STROMA CELL;

ANIMALS; BRAIN NEOPLASMS; DRUG CARRIERS; MESODERM; NANOPARTICLES; STROMAL CELLS;

EID: 79955015307     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2011273234     Document Type: Article

References (11)

1. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-66.
2. Kosztowski T, Zaidi HA, Quinones-Hinojosa A. Applications of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev Anticancer Ther 2009; 9: 597-612.
3. Delcroix GJ, Curtis KM, Schiller PC, et al. EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells. Differentiation 2010; 80: 213-27.
4. Bexell D, Scheding S, Bengzon J. Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors. Mol Ther 2010; 18: 1067-75.
5. Horcajada P, Serre C, Férey G, et al. Des nanovecteurs hybrides pour la restitution retard de médicaments antitumoraux et antiviraux. Med Sci (Paris) 2010; 26: 761-7.
6. Jain KK. Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert RevNeurother 2007; 7: 363-72.
7. Roger M, Clavreul A, Venier-Julienne MC, et al. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 2010; 31: 8393-401.
8. Roger M, Clavreul A, Venier-Julienne MC, et al. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. Biomaterials 2011; 32: 2106-16.
9. Charbord P, Casteilla L. La biologie des cellules souches mésenchymateuses d’origine humaine. Med Sci (Paris) 2011; 27: 261-8.
10. Vinatier C, Bordenave L, Guicheux J, Amédée J. Les cellules souches en ingénierie des tissus ostéoarticulaires et vasculaires. Med Sci (Paris) 2011; 27: 289-96.
11. Lazennec G. Les cellules souches mésenchymateuses: armes ou dangers pour le traitement des cancers ? Med Sci (Paris) 2011; 27: 285-8.